id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S15841 R65203 |
Bromley (Lamotrigine) (Epilepsy), 2023 | Preterm birth (gestational age < 37 weeks) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 1.03 [0.45;2.39] C | 15/106 11/80 | 26 | 106 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12612 R47531 |
Van Marter (Controls unexposed, disease free), 2021 | Premature (≤36 wk) | at least 1st trimester | prospective cohort | unexposed, disease free excluded | Adjustment: No |
0.77 [0.31;1.94] C excluded (control group) |
9/110 11/106 | 20 | 110 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12614 R47543 |
Van Marter (Controls unexposed, sick), 2021 | Premature (≤36 wk) | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 1.25 [0.15;10.61] C | 9/110 1/15 | 10 | 110 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8077 R24648 |
Aydin, 2020 | Preterm delivery (before 37 weeks of gestation) | throughout pregnancy | retrospective cohort | unexposed, sick | Adjustment: No | 0.60 [0.03;14.19] C | 0/7 2/22 | 2 | 7 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S7996 R24600 |
Cohen, 2019 | Preterm birth (ICD-9 644.2, 774.2, 776.6, 362.20, 362.22, 362.27, 765 excluding 765.20, 765.29) | early pregnancy | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes | 0.92 [0.67;1.27] | -/- 160,604/1,440,631 | 160,595 | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5546 R18858 |
Miškov (Controls unexposed, disease free), 2016 | Premature deliveries | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No |
2.58 [0.45;14.91] C excluded (control group) |
2/26 4/128 | 6 | 26 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S7411 R21809 |
Miškov (Controls unexposed, sick), 2016 | Premature deliveries | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 0.74 [0.03;18.97] C | 2/26 0/4 | 2 | 26 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5912 R14922 |
Artama (Controls unexposed, disease free), 2013 | Preterm birth (<37 gestational weeks) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
0.98 [0.48;2.00] excluded (control group) |
8/173 30,027/719,509 | 30,035 | 173 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5920 R15018 |
Artama (Controls unexposed, sick), 2013 | Preterm birth (<37 gestational weeks) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 1.00 [0.46;2.16] | 8/173 85/1,793 | 93 | 173 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6394 R17469 |
Veiby (Controls unexposed, disease free) b, 2013 | Preterm delivery (< 37 weeks) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No |
0.90 [0.40;2.00] excluded (control group) |
7/103 7,269/106,899 | 7,276 | 103 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6393 R17450 |
Veiby (Controls unexposed, sick) b, 2013 | Preterm delivery (< 37 weeks) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 0.87 [0.37;2.03] C | 7/103 30/386 | 37 | 103 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6940 R19598 |
Cummings, 2011 | Preterm (35-37 weeks) | throughout pregnancy | retrospective cohort (registry) | unexposed, disease free | Adjustment: No | 16.22 [0.86;304.56] C | 5/35 0/44 | 5 | 35 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 8 studies | 0.96 [0.74;1.24] | 160,770 | 560 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Lamotrigine) (Epilepsy; 2: Controls unexposed, sick; 3: Controls unexposed, sick; 4: Controls unexposed, sick; 5: Controls unexposed, sick) ;
Asymetry test p-value = 0.2994 (by Egger's regression)
slope=-0.1729 (0.1483); intercept=0.4486 (0.3950); t=1.1358; p=0.2994
excluded 5912, 6394, 5546, 12612